Liaoning Chengda BiotechnologyLtd Balance Sheet Health
Financial Health criteria checks 5/6
Liaoning Chengda BiotechnologyLtd has a total shareholder equity of CN¥9.7B and total debt of CN¥5.0M, which brings its debt-to-equity ratio to 0.05%. Its total assets and total liabilities are CN¥10.1B and CN¥439.0M respectively. Liaoning Chengda BiotechnologyLtd's EBIT is CN¥475.6M making its interest coverage ratio -5. It has cash and short-term investments of CN¥5.6B.
Key information
0.05%
Debt to equity ratio
CN¥4.97m
Debt
Interest coverage ratio | -5x |
Cash | CN¥5.58b |
Equity | CN¥9.66b |
Total liabilities | CN¥438.98m |
Total assets | CN¥10.10b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688739's short term assets (CN¥7.2B) exceed its short term liabilities (CN¥326.1M).
Long Term Liabilities: 688739's short term assets (CN¥7.2B) exceed its long term liabilities (CN¥112.9M).
Debt to Equity History and Analysis
Debt Level: 688739 has more cash than its total debt.
Reducing Debt: 688739's debt to equity ratio has increased from 0% to 0.05% over the past 5 years.
Debt Coverage: 688739's debt is well covered by operating cash flow (12114%).
Interest Coverage: 688739 earns more interest than it pays, so coverage of interest payments is not a concern.